| Original language | English (US) |
|---|---|
| Pages (from-to) | e285-e350 |
| Journal | Journal of the American College of Cardiology |
| Volume | 73 |
| Issue number | 24 |
| DOIs | |
| Publication status | Published - 25 Jun 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ACC/AHA Clinical Practice Guidelines
- Guidelines
- LDL-cholesterol
- biomarkers
- cardiovascular disease
- cholesterol
- coronary artery calcium score
- diabetes mellitus
- drug therapy
- ezetimibe
- hydroxymethylglutaryl-CoA reductase inhibitors/statins
- hypercholesterolemia
- lipids
- patient compliance
- pharmacological
- primary prevention
- proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors
- risk assessment
- risk reduction discussion
- risk treatment discussion
- secondary prevention
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver